Divergent roles for p55 and p75 tumor necrosis factor receptors in the pathogenesis of MOG(35-55)-induced experimental autoimmune encephalomyelitis.
about
The genetic association of variants in CD6, TNFRSF1A and IRF8 to multiple sclerosis: a multicenter case-control studyThe intriguing biology of the tumour necrosis factor/tumour necrosis factor receptor superfamily: players, rules and the gamesTranslational utility of experimental autoimmune encephalomyelitis: recent developmentsVitamin D receptor agonists: suitable candidates as novel therapeutic options in autoimmune inflammatory myopathyTargeting TNF receptors in rheumatoid arthritisRole of the immunogenic and tolerogenic subsets of dendritic cells in multiple sclerosisRole of tumour necrosis factor (TNF)-α and TNFRSF1A R92Q mutation in the pathogenesis of TNF receptor-associated periodic syndrome and multiple sclerosis.Central but not systemic administration of XPro1595 is therapeutic following moderate spinal cord injury in miceAttenuated EAN in TNF-α deficient mice is associated with an altered balance of M1/M2 macrophages.An intracameral injection of antigen induces in situ chemokines and cytokines required for the generation of circulating immunoregulatory monocytes.Accelerated pathological and clinical nephritis in systemic lupus erythematosus-prone New Zealand Mixed 2328 mice doubly deficient in TNF receptor 1 and TNF receptor 2 via a Th17-associated pathwayTNFR2 maintains adequate IL-12 production by dendritic cells in inflammatory responses by regulating endogenous TNF levels.The vitamin D receptor agonist BXL-01-0029 as a potential new pharmacological tool for the treatment of inflammatory myopathiesGeneration and characterization of small single domain antibodies inhibiting human tumor necrosis factor receptor 1.Antibody-mediated inhibition of TNFR1 attenuates disease in a mouse model of multiple sclerosis.Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelinationTNFR2 Deficiency Acts in Concert with Gut Microbiota To Precipitate Spontaneous Sex-Biased Central Nervous System Demyelinating Autoimmune Disease.Heterogeneity of microglia and TNF signaling as determinants for neuronal death or survivalGenetic determinants of risk and progression in multiple sclerosis.Progress in multiple sclerosis genetics.Systems-based medicine approaches to understand and treat complex diseases. The example of multiple sclerosis.Oligodendroglial TNFR2 Mediates Membrane TNF-Dependent Repair in Experimental Autoimmune Encephalomyelitis by Promoting Oligodendrocyte Differentiation and Remyelination.Genetic and Molecular Basis of QTL of Diabetes in Mouse: Genes and PolymorphismsCutting edge: expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+FoxP3+ T regulatory cells: applicability to tumor-infiltrating T regulatory cells.TNF-α Autocrine Feedback Loops in Human Monocytes: The Pro- and Anti-Inflammatory Roles of the TNF-α Receptors Support the Concept of Selective TNFR1 Blockade In Vivo.A trifluoromethyl analogue of celecoxib exerts beneficial effects in neuroinflammation.Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned.Concomitant rheumatoid arthritis and amyotrophic lateral sclerosis: report of two new cases and review of literature.The tumour necrosis factor/TNF receptor superfamily: therapeutic targets in autoimmune diseases.Cytokines and effector T cell subsets causing autoimmune CNS disease.Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system.Demyelination during tumour necrosis factor antagonist therapy for psoriasis: a case report and review of the literature.Cytokine control of inflammation and repair in the pathology of multiple sclerosis.Interrelation of oxidative stress and inflammation in neurodegenerative disease: role of TNF.Inflammatory Cytokines Are Involved in Focal Demyelination in Leprosy Neuritis.Cytokine networks in neuroinflammation.Immunomodulation of autoimmune arthritis by pro-inflammatory cytokines.A clinical conundrum: the detrimental effect of TNF antagonists in multiple sclerosis.Pathogenic T cells have a paradoxical protective effect in murine autoimmune diabetes by boosting Tregs.TNFR1 inhibition with a Nanobody protects against EAE development in mice.
P2860
Q21560832-FA1EAB1D-09E7-4713-808C-82BCC6D9E543Q24683018-3005EF10-380D-431B-9D57-CB2BCF1812C3Q26775820-9C7B8BC0-ABFC-4314-AD93-27EC69EDE2C1Q26849424-7EBDCD61-E61C-4DB7-855A-0B2353D9B140Q26853279-FD5FF7CC-B6C1-492E-AE6D-AD870F23DD24Q28082878-F07735D7-816A-4809-A02A-2CAB7DD3F004Q33352461-D7724BF7-FA58-4183-8A2C-C56428F4A18BQ34250544-CE1652AB-0EB1-461D-BF69-7E12C4A648ADQ34292861-7172C764-1069-4F68-8AFC-633067E2277AQ34389392-E3A0B8F7-9446-419A-AFBA-4F6BF1CCDE4DQ34939962-86822115-FD48-4D9B-8DF3-2B515F0B43BEQ35016512-B5B9DF7B-4659-454D-84C9-3FEC6A045537Q35035562-2E15F8A4-7DEC-4A2A-AA8A-DBAD5A462699Q35080243-89C1AC84-8D1A-4F86-9882-89BF470D7BD8Q35108700-1756113B-9834-46CD-875C-A22FF0B8CF88Q35206971-7049B69A-E7EA-4344-B1EC-2C99E16E9FA9Q35811308-E7395C53-B85B-4906-93AB-846DCA83280BQ35898094-DFC1EA8F-E09E-444A-82B6-C979D3787D07Q35915818-7601932F-ACFB-4973-955C-60C8CCE9C5BBQ36382352-67CA16E9-8C27-4DE5-9EC4-CDCFCFF939A3Q36687908-69310198-8B61-4BD2-8FAF-5D043AE08FB0Q36863995-7C1EBC5F-ECB9-41F8-BD2C-217ED3C3EAD4Q37200819-7B8BC249-3A20-47BA-9EDF-B0CC7D2B1537Q37236554-9F34A371-0026-4ABF-BD33-E098E2448010Q37322789-0F19B0CF-30B6-4924-B957-A5C90D228812Q37384508-D7FE917F-E804-4E48-82EC-AB1BF7E951EBQ37634375-B2261A45-1CD8-4FEE-BD66-9CE9D72D50C9Q37831814-92F4F896-EA13-4E70-BCF0-BF544ED3EE46Q37852758-5EC9CC98-BF70-4FC6-A44D-3D2F179DD4D8Q37863274-E6B6628F-C859-4EA9-8A10-A05477732C7AQ37897498-93D387D1-3108-4FBF-BA60-76B5B21FBFADQ37977994-9051BF70-6796-41AF-9AA9-EC4B65B8D7F6Q38067389-C40CECC7-6BAB-4A91-BF1F-E27EDCF938D3Q38401306-D8A9D546-9661-4D21-B86D-B520EF2431F0Q38793309-4DD3E7B5-8BD7-40FB-9684-89FF868293F0Q39029104-A263CB4E-963D-4DB6-A77F-AD7FC3542EDDQ39259474-1E856E5B-F202-49C5-A9A3-9071B0B2552FQ39352140-AA5E6D34-312C-472A-9B29-947C270CE2F7Q41446869-E0FA935D-12AA-46F6-9151-B0D7F598BF3BQ42653357-955D7CE1-945A-4EBD-9F20-8083EF2867FB
P2860
Divergent roles for p55 and p75 tumor necrosis factor receptors in the pathogenesis of MOG(35-55)-induced experimental autoimmune encephalomyelitis.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Divergent roles for p55 and p7 ...... ors in the pathogenesis of MOG
@nl
Divergent roles for p55 and p7 ...... autoimmune encephalomyelitis.
@en
type
label
Divergent roles for p55 and p7 ...... ors in the pathogenesis of MOG
@nl
Divergent roles for p55 and p7 ...... autoimmune encephalomyelitis.
@en
prefLabel
Divergent roles for p55 and p7 ...... ors in the pathogenesis of MOG
@nl
Divergent roles for p55 and p7 ...... autoimmune encephalomyelitis.
@en
P2093
P356
P1433
P1476
Divergent roles for p55 and p7 ...... autoimmune encephalomyelitis.
@en
P2093
Barrett TA
Dal Canto MC
Suvannavejh GC
P356
10.1006/CIMM.2000.1706
P577
2000-10-01T00:00:00Z